SCHEMBL6935569

SCHEMBL6935569

C=Cc1ccc(C=C)cc1.[KH]

nearest known ligand 0.92

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.92
TSHR P16473 1/20 0.62
HDAC8 Q9BY41 3/20 0.50
TDP1 Q9NUW8 2/20 0.50
TP53 P04637 1/20 0.39
TRPA1 O75762 1/20 0.37
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA7 P36544 1/20 0.37
CHRNA4 P43681 1/20 0.37
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33
DAPK3 O43293 1/20 0.32
JAK2 O60674 1/20 0.32
ABL1 P00519 1/20 0.32
NTRK1 P04629 1/20 0.32
FYN P06241 1/20 0.32
CSF1R P07333 1/20 0.32
RET P07949 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7639 0.96 ALDH1A1 (1.00) ALDH1A1TSHRHDAC8TDP1TP53
SCHEMBL473081 0.96 ALDH1A1 (1.00) ALDH1A1TSHRHDAC8TDP1TP53
Ethylene SCHEMBL7955374 0.92 ALDH1A1 (0.92) ALDH1A1TSHRHDAC8TDP1TP53
Ammonia Solution, Strong SCHEMBL28837807 0.92 ALDH1A1 (0.92) ALDH1A1TSHRHDAC8TDP1TP53
SCHEMBL10426886 0.92 ALDH1A1 (0.92) ALDH1A1TSHRHDAC8TDP1TP53
Hydrochloric Acid SCHEMBL23581954 0.92 ALDH1A1 (0.92) ALDH1A1TSHRHDAC8TDP1TP53
Water SCHEMBL20378930 0.92 ALDH1A1 (0.92) ALDH1A1TSHRHDAC8TDP1TP53
SCHEMBL29229894 0.92 ALDH1A1 (0.92) ALDH1A1TSHRHDAC8TDP1TP53
SCHEMBL22496003 0.92 ALDH1A1 (0.92) ALDH1A1TSHRHDAC8TDP1TP53
Water SCHEMBL28759143 0.92 ALDH1A1 (0.92) ALDH1A1TSHRHDAC8TDP1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2063872-B1 CONTROLLED RELEASE ORAL DOSAGE FORMULATIONS COMPRISING A CORE AND ONE OR MORE BARRIER LAYERS JAGOTEC AG (CH) 2015-05-06 EP claimed
EP-1019029-B1 MONOLITHIC SYSTEM CONTAINING ONE OR MORE DRUGS, CONSISTING OF THREE LAYERS WITH DIFFERENT RELEASE MECHANISMS CHIESI FARMA SPA (IT) 2003-09-03 EP claimed